Olgun Yıldızeli, S. Et Al. 2023. Pre-existing Immunocompromised Status as a Preventer of Mortality in COVID-19 Patients: Friend or Foe?. Cureus , vol.15, no.4 .

Olgun Yıldızeli, S., Vezir, D., Cimsit, C., Kocakaya, D., Mercanci, Z., Balcan, B., ... Ermerak, O.(2023). Pre-existing Immunocompromised Status as a Preventer of Mortality in COVID-19 Patients: Friend or Foe?. Cureus , vol.15, no.4.

Olgun Yıldızeli, Sehnaz Et Al. "Pre-existing Immunocompromised Status as a Preventer of Mortality in COVID-19 Patients: Friend or Foe?," Cureus , vol.15, no.4, 2023

Olgun Yıldızeli, Sehnaz O. Et Al. "Pre-existing Immunocompromised Status as a Preventer of Mortality in COVID-19 Patients: Friend or Foe?." Cureus , vol.15, no.4, 2023

Olgun Yıldızeli, S. Et Al. (2023) . "Pre-existing Immunocompromised Status as a Preventer of Mortality in COVID-19 Patients: Friend or Foe?." Cureus , vol.15, no.4.

@article{article, author={Sehnaz Olgun Yıldızeli Et Al. }, title={Pre-existing Immunocompromised Status as a Preventer of Mortality in COVID-19 Patients: Friend or Foe?}, journal={Cureus}, year=2023}